Karo Bio
Karo Bio researches and develops drugs based on the nuclear receptors for the treatment of neuropsychiatry, autoimmune and cancer disorders.
Business Model:
Revenue: $3.8M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Karo Bio Information
Geographic Data
Address: Hälsovägen 7
City: Huddinge
State: stockholms län
Zip: 141 57
Country: SE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$30M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Karo Bio researches and develops drugs based on the nuclear receptors for the treatment of neuropsychiatry, autoimmune and cancer disorders.
Contact Phone:
Contact Email:
Karo Bio went public on the Nasdaq OMX Nordic
Listed Exchange:
Nasdaq OMX Nordic
Ticker Symbol:
KARO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2016 | Equity | $30M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2000 | Novalon Pharmaceutical |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
